Compare ATRC & PENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | PENN |
|---|---|---|
| Founded | 2000 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.2B |
| IPO Year | 2005 | 1996 |
| Metric | ATRC | PENN |
|---|---|---|
| Price | $57.29 | $15.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 20 |
| Target Price | ★ $54.89 | $24.29 |
| AVG Volume (30 Days) | 1.4M | ★ 3.0M |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.74 | N/A |
| EPS | 0.18 | ★ 0.23 |
| Revenue | $201,630,000.00 | ★ $6,362,900,000.00 |
| Revenue This Year | $13.42 | $6.69 |
| Revenue Next Year | $12.12 | $4.24 |
| P/E Ratio | $307.50 | ★ $67.15 |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $25.36 | $11.65 |
| 52 Week High | $61.70 | $22.36 |
| Indicator | ATRC | PENN |
|---|---|---|
| Relative Strength Index (RSI) | 58.35 | 40.29 |
| Support Level | $26.95 | $14.64 |
| Resistance Level | $61.70 | $15.42 |
| Average True Range (ATR) | 2.50 | 0.51 |
| MACD | -0.68 | 0.13 |
| Stochastic Oscillator | 55.81 | 66.75 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 42 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 81% of total sales in 2025; 19% was from the interactive segment, which includes sports, i-gaming, and media revenue. The retail portfolio generates low-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media asset, theScore, provides access to sports betting/i-gaming technology and clientele, helping it form a leading digital position.